The experimental drug IC7Fc, originally designed to control type 2 diabetes, reduces cholesterol, blood fats and artery-clogging plaque. It also soothes the inflammation associated with heart attacks and strokes. These benefits occurred without weight loss. The drug can also help slim people at risk of heart disease. Researchers have found these effects in experimental research.